Find clinical trials for AstraZeneca. Search for AstraZeneca clinical trials in different cities and states across the United States.
Filter
Filter results
Results: 147
New
Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations
for
Transthyretin Amyloidosis,
Location: Vancouver, Los Angeles CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07654855
Recruiting
New
Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
for
Kidney Failure
Location: Orlando FL
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07754331
Phase1, Recruiting
New
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
for
HER2-positive Gastric Cancer,
Location: Chicoutimi, New York NY, Summit NJ, Montreal,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06764875
Phase3, Recruiting
Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure
for
Chronic Lymphocytic Leukaemia,
Location: Philadelphia PA, Columbus OH
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06651970
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Sydney, Saint John, Scarborough ME, West Haven CT,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase3, Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Fairhaven MA, Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase3, Recruiting
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
for
Moderate Hepatic Impairment
Location: San Antonio TX, Rialto CA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT07343960
Phase1, Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
for
Systemic Lupus Erythematosus,
Location: Sherbrooke, Anniston AL, Iowa City IA
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06916806
Phase1, Recruiting
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
for
Non-small Cell Lung Cancer,
Location: Boston MA, New York NY, New Brunswick NJ, Pittsburgh PA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05877599
Phase1, Recruiting
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
for
Metastatic Castration-Resistant Prostate Cancer
Location: Boston MA, Miami FL, Tampa FL, Chicago IL, Omaha NE
Sponsor: AstraZeneca
Sex: Male
Age: 18+
Code: NCT06879041
Phase1, Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
for
Diffuse Large B-Cell Lymphoma
Location: Des Moines IA, Tacoma WA
Sponsor: AstraZeneca
Sex: All
Age: 65 - 70+
Code: NCT05952024
Phase2, Recruiting
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
for
Relapsed/Refractory Multiple Myeloma
Location: Boston MA, Stony Brook NY, New York NY,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT05850234
Phase1, Phase2, Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
for
B-cell Acute Lymphoblastic Leukemia (B-ALL)
Location: New York NY, Richmond VA, Tampa FL, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT06137118
Phase1, Phase2, Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
for
Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,
Location: Boston MA, Providence RI, New York NY, Hackensack NJ,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06564038
Phase1, Phase2, Recruiting
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer
Location: Boston MA, New Haven CT, Montreal, Baltimore MD,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05061550
Phase2, Recruiting
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Trenton NJ, Montreal, Baltimore MD, Washington D.C. DC,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06792695
Phase2, Recruiting
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2